Pharmala Biotech Holdings Inc. (MDXXF) News
Follow Pharmala Biotech Holdings Inc. (MDXXF) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Psychedelic: PharmAla enters license agreement with Jupiter Neurosciences
In this week's "Psychedelic," recurring series focused on psychedelic stock news, looks back on a license agreement, enrollment completion and a patent filing. PHARMALA, JUPITER ENTER LICENSE AGREEMENT: PharmAla Biotech
EQUITY | Jul 23, 2026, 03:07 PM UTC
L
Psychedelic: Compass Pathways reports six-month data for psilocybin drug
In this week's "Psychedelic," recurring series focused on psychedelic stock news, looks back on study results, drug delivery evaluation and last patient dosing. COMPASS PATHWAYS REPORTS SIX-MONTH DATA FROM COMP006 TRIAL:
EQUITY | Jul 09, 2026, 01:49 PM UTC